Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
mariavaleria.giuli@uniroma1.it
Maria Valeria Giuli
Dottorando
Struttura:
DIPARTIMENTO DI SCIENZE E BIOTECNOLOGIE MEDICO-CHIRURGICHE
E-mail:
mariavaleria.giuli@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Dilated cardiomyopathy due to a novel combination of TTN and BAG3 genetic variants: From acute heart failure to subclinical phenotypes
CARDIOVASCULAR PATHOLOGY
2024
Structuring lipid nanoparticles, DNA, and protein corona into stealth bionanoarchitectures for in vivo gene delivery
NATURE COMMUNICATIONS
2024
pH-sensitive niosomes for ATRA delivery: A promising approach to inhibit Pin1 in high-grade serous ovarian cancer
INTERNATIONAL JOURNAL OF PHARMACEUTICS
2023
Opsonin-deficient nucleoproteic corona Endows unPEGylated liposomes with stealth properties in vivo
ACS NANO
2022
Human duodenal submucosal glands contain a defined stem/progenitor subpopulation with liver-specific regenerative potential
JOURNAL OF HEPATOLOGY
2022
5FU/Oxaliplatin-induced Jagged1 cleavage counteracts apoptosis induction in colorectal cancer: a novel mechanism of intrinsic drug resistance
FRONTIERS IN ONCOLOGY
2022
Notch signaling in female cancers. A multifaceted node to overcome drug resistance
CANCER DRUG RESISTANCE
2021
Notch3 contributes to T-cell leukemia growth via regulation of the unfolded protein response
ONCOGENESIS
2020
Current trends in ATRA delivery for cancer therapy
PHARMACEUTICS
2020
ProAlanase is an effective alternative to trypsin for proteomics applications and disulfide bond mapping
MOLECULAR & CELLULAR PROTEOMICS
2020
Notch signaling activation as a hallmark for triple-negative breast cancer subtype
JOURNAL OF ONCOLOGY
2019
Molecular basis of Notch3-Pin1 functional crosstalk in aggressive female tumors: therapeutic targeting implications in ovarian cancer treatment
PATHOBIOLOGY: FROM MOLECULAR DISEASE TO CLINICAL APPLICATION
2019
Notch3-Pin1 crosstalk in ovarian cancer: from molecular mechanism dissection to therapeutic application
The XI Notch meeting
2019
Getting insights into Pin1-Notch3 functional crosstalk in ovarian cancer
NEW TECHNOLOGIES TO FIGHT CANCER
2019
Notch3 contributes to T-cell leukemia growth via regulation of the unfolding protein response
The Biennial Congress of the Italian Association of cell biology and differentiation
2019
NOTCH3 inactivation increases Triple Negative Breast Cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest.
Atti del ABCD - PPh.D. meeting
2018
NOTCH3 inactivation increases triple negative breast cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest.
ONCOGENESIS
2018
Targeting the ER/UPR signalling in Notch3-overexpressing T-cell acute lymphoblastic leukemia.
Atti del ABCD - Ph.D. meeting
2018
Potential targeted therapy for T-cell acute lymphoblastic leukemia: perturbing ER/UPR signaling via Notch3 down-regulation
Cell communication and signaling: how to turn bad language into positive one
2018
Cytotoxic activity of Juglone against Notch3-overexpressing T-cell acute lymphoblastic leukemia: targeting the ER/UPR signaling
Notch meeting X
2017
1
2
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma